Product Information
LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Camber Consumer Care, priced at $0.2183 per EA under NDC 69230032110. Its NADAC has been published 264 times since Sep 15, 2021.
FDA first approved this application on Apr 29, 2020.
Strength
5 mg/1
Manufacturer
Camber Consumer CareNDC
69230032110
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213513FDA Approved
4/29/2020
On Market Since
10/28/2020
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 264 times since Sep 15, 2021, and over the history we have for it it has risen 12.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2183 per EA |
|---|---|
| All-time high | $0.2231 (Aug 12, 2026) |
| All-time low | $0.1424 (Aug 17, 2022) |
| 52-week high | $0.2231 |
| 52-week low | $0.1830 |
| Median price | $0.1843 |
| Average price | $0.1842 |
| Largest weekly change | +48.3% (Sep 21, 2022) |
| Weeks tracked | 264 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Consumer Care manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levocetirizine Dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Camber Consumer Care, is $0.2183 per EA (NDC 69230032110), effective Sep 30, 2026.
How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has risen 12.9%. It has been tracked across 264 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?
Since Sep 15, 2021, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.1424 (Aug 17, 2022) to a high of $0.2231 (Aug 12, 2026), with a median of $0.1843 per EA.
Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOCETIRIZINE 5 MG TABLET, is $0.0511 per EA — about 77% below LEVOCETIRIZINE 5 MG TABLET.
Who manufactures LEVOCETIRIZINE 5 MG TABLET?
LEVOCETIRIZINE 5 MG TABLET (NDC 69230032110) is labeled by Camber Consumer Care, and CMS classifies it as a generic product.